WELLESLEY HILLS, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished leader, with over 17 years of experience in the pharmaceutical and biotech industry. “I am delighted to welcome Dr. Perrin Wilson to the Climb Bio management team,” said Aoife Brennan, President and CEO of Climb Bio. “Perrin brings extensive experience and a track record of success across large phRead More
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
